Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Agent Docetaxel in Elderly Metastatic Breast Cancer
NCT00025493Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 2001
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in breast cancer, sponsored by SWOG Cancer Research Network. Primary endpoint: Study treatment feasibility. Started Oct 2001; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00025493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025493.